心臓移植治療の世界市場2024~2028

◆英語タイトル:Global Heart Transplantation Therapeutics Market 2024-2028

Technavioが発行した調査報告書(IRTNTR40272-24)◆商品コード:IRTNTR40272-24
◆発行会社(リサーチ会社):Technavio
◆発行日:2024年1月
◆ページ数:約120
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア太平洋、その他地域
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥370,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

心臓移植治療薬の世界市場 2024-2028
心臓移植治療薬市場は2023-2028年に135.37百万米ドルで成長し、予測期間中のCAGRは3.24%で加速すると予測されます。この調査レポートは、心臓移植治療薬市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題を掲載し、約25のベンダーを網羅したベンダー分析も掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、心血管疾患や心不全の有病率の上昇、複数の剤形の薬剤の入手可能性、心臓移植における免疫抑制剤への依存度の高さによって牽引されています。

Technavioの心臓移植治療薬市場は以下のように区分されます:

薬剤クラス別
• 免疫抑制剤
• 抗感染薬
• 鎮痛薬
• その他

流通チャネル別
• 病院薬局
• 小売薬局
• オンライン薬局

地域別
• 北米
• ヨーロッパ
• アジア
• その他の地域(ROW)

本調査では、今後数年間の心臓移植治療薬市場の成長を促進する主な理由の1つとして、心臓移植に関する国際的な協力関係の拡大を挙げています。また、心臓移植のための技術の出現や、心臓移植に関する認知度やアクセス性の向上は、市場の大きな需要につながるでしょう。

このレポートは心臓移植治療薬市場を調査し、以下の調査分野をカバーしています:
• 心臓移植治療薬市場のサイジング
• 心臓移植治療薬市場の予測
• 心臓移植治療薬市場の産業分析

強固なベンダー分析は、クライアントが市場での地位を向上できるように設計されており、これに沿って、本レポートでは、AbbVie Inc.、Astellas Pharma Inc.、Biocon Ltd.、Dr Reddys Laboratories Ltd.、Endo International Plc.、Glax International Ltd.、 Endo International Plc、GlaxoSmithKline Plc、Glenmark Pharmaceuticals Ltd.、Intas Pharmaceuticals Ltd.、Jubilant Pharmova Ltd.、LEO Pharma AS、Lupin Ltd.、McKesson Corp.、Novartis AG、Pfizer Inc.、RPG Enterprises、Strides Pharma Science Ltd.、Sun Pharmaceutical Industries Ltd.、Teva Pharmaceutical Industries Ltd.、F. Hoffmann La Roche Ltd.、Panacea Biotec Ltd.などの心臓移植治療薬市場の主要ベンダーの詳細な分析を提供しています。また、心臓移植治療薬市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場および企業状況プが含まれています。

当出版社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

1 エグゼクティブサマリー
2 市場状況
3 市場規模
4 過去の市場規模
5 ファイブフォース分析
6 心臓移植治療の世界市場:薬効分類別
7 心臓移植治療の世界市場:流通チャネル別
8 顧客状況
9 地域別状況
10 推進要因・課題・動向
11 企業状況
12 企業分析
13 付録

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Drug Class
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global heart transplantation therapeutics market 2018 – 2022
o Exhibit 18: Historic Market Size – Data Table on global heart transplantation therapeutics market 2018 – 2022 ($ million)
o 4.2 Drug Class Segment Analysis 2018 – 2022
o Exhibit 19: Historic Market Size – Drug Class Segment 2018 – 2022 ($ million)
o 4.3 Distribution Channel Segment Analysis 2018 – 2022
o Exhibit 20: Historic Market Size – Distribution Channel Segment 2018 – 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 – 2022
o Exhibit 21: Historic Market Size – Geography Segment 2018 – 2022 ($ million)
o 4.5 Country Segment Analysis 2018 – 2022
o Exhibit 22: Historic Market Size – Country Segment 2018 – 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2023 and 2028
• 6 Market Segmentation by Drug Class
o 6.1 Market segments
o Exhibit 30: Chart on Drug Class – Market share 2023-2028 (%)
o Exhibit 31: Data Table on Drug Class – Market share 2023-2028 (%)
o 6.2 Comparison by Drug Class
o Exhibit 32: Chart on Comparison by Drug Class
o Exhibit 33: Data Table on Comparison by Drug Class
o 6.3 Immunosuppressants – Market size and forecast 2023-2028
o Exhibit 34: Chart on Immunosuppressants – Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on Immunosuppressants – Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on Immunosuppressants – Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Immunosuppressants – Year-over-year growth 2023-2028 (%)
o 6.4 Anti-infectives – Market size and forecast 2023-2028
o Exhibit 38: Chart on Anti-infectives – Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on Anti-infectives – Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on Anti-infectives – Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Anti-infectives – Year-over-year growth 2023-2028 (%)
o 6.5 Analgesics – Market size and forecast 2023-2028
o Exhibit 42: Chart on Analgesics – Market size and forecast 2023-2028 ($ million)
o Exhibit 43: Data Table on Analgesics – Market size and forecast 2023-2028 ($ million)
o Exhibit 44: Chart on Analgesics – Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Analgesics – Year-over-year growth 2023-2028 (%)
o 6.6 Others – Market size and forecast 2023-2028
o Exhibit 46: Chart on Others – Market size and forecast 2023-2028 ($ million)
o Exhibit 47: Data Table on Others – Market size and forecast 2023-2028 ($ million)
o Exhibit 48: Chart on Others – Year-over-year growth 2023-2028 (%)
o Exhibit 49: Data Table on Others – Year-over-year growth 2023-2028 (%)
o 6.7 Market opportunity by Drug Class
o Exhibit 50: Market opportunity by Drug Class ($ million)
o Exhibit 51: Data Table on Market opportunity by Drug Class ($ million)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 52: Chart on Distribution Channel – Market share 2023-2028 (%)
o Exhibit 53: Data Table on Distribution Channel – Market share 2023-2028 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 54: Chart on Comparison by Distribution Channel
o Exhibit 55: Data Table on Comparison by Distribution Channel
o 7.3 Hospital pharmacies – Market size and forecast 2023-2028
o Exhibit 56: Chart on Hospital pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 57: Data Table on Hospital pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 58: Chart on Hospital pharmacies – Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Hospital pharmacies – Year-over-year growth 2023-2028 (%)
o 7.4 Retail pharmacies – Market size and forecast 2023-2028
o Exhibit 60: Chart on Retail pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 61: Data Table on Retail pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 62: Chart on Retail pharmacies – Year-over-year growth 2023-2028 (%)
o Exhibit 63: Data Table on Retail pharmacies – Year-over-year growth 2023-2028 (%)
o 7.5 Online pharmacies – Market size and forecast 2023-2028
o Exhibit 64: Chart on Online pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 65: Data Table on Online pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 66: Chart on Online pharmacies – Year-over-year growth 2023-2028 (%)
o Exhibit 67: Data Table on Online pharmacies – Year-over-year growth 2023-2028 (%)
o 7.6 Market opportunity by Distribution Channel
o Exhibit 68: Market opportunity by Distribution Channel ($ million)
o Exhibit 69: Data Table on Market opportunity by Distribution Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 73: Chart on Geographic comparison
o Exhibit 74: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2023-2028
o Exhibit 75: Chart on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on North America – Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on North America – Year-over-year growth 2023-2028 (%)
o 9.4 Europe – Market size and forecast 2023-2028
o Exhibit 79: Chart on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on Europe – Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Europe – Year-over-year growth 2023-2028 (%)
o 9.5 Asia – Market size and forecast 2023-2028
o Exhibit 83: Chart on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on Asia – Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Asia – Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2023-2028
o Exhibit 87: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o 9.7 US – Market size and forecast 2023-2028
o Exhibit 91: Chart on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on US – Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on US – Year-over-year growth 2023-2028 (%)
o 9.8 Germany – Market size and forecast 2023-2028
o Exhibit 95: Chart on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on Germany – Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on Germany – Year-over-year growth 2023-2028 (%)
o 9.9 UK – Market size and forecast 2023-2028
o Exhibit 99: Chart on UK – Market size and forecast 2023-2028 ($ million)
o Exhibit 100: Data Table on UK – Market size and forecast 2023-2028 ($ million)
o Exhibit 101: Chart on UK – Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on UK – Year-over-year growth 2023-2028 (%)
o 9.10 Japan – Market size and forecast 2023-2028
o Exhibit 103: Chart on Japan – Market size and forecast 2023-2028 ($ million)
o Exhibit 104: Data Table on Japan – Market size and forecast 2023-2028 ($ million)
o Exhibit 105: Chart on Japan – Year-over-year growth 2023-2028 (%)
o Exhibit 106: Data Table on Japan – Year-over-year growth 2023-2028 (%)
o 9.11 France – Market size and forecast 2023-2028
o Exhibit 107: Chart on France – Market size and forecast 2023-2028 ($ million)
o Exhibit 108: Data Table on France – Market size and forecast 2023-2028 ($ million)
o Exhibit 109: Chart on France – Year-over-year growth 2023-2028 (%)
o Exhibit 110: Data Table on France – Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 111: Market opportunity By Geographical Landscape ($ million)
o Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 113: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 115: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 116: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 117: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 118: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 119: AbbVie Inc. – Overview
o Exhibit 120: AbbVie Inc. – Product / Service
o Exhibit 121: AbbVie Inc. – Key news
o Exhibit 122: AbbVie Inc. – Key offerings
o 12.4 Astellas Pharma Inc.
o Exhibit 123: Astellas Pharma Inc. – Overview
o Exhibit 124: Astellas Pharma Inc. – Product / Service
o Exhibit 125: Astellas Pharma Inc. – Key news
o Exhibit 126: Astellas Pharma Inc. – Key offerings
o 12.5 Biocon Ltd.
o Exhibit 127: Biocon Ltd. – Overview
o Exhibit 128: Biocon Ltd. – Business segments
o Exhibit 129: Biocon Ltd. – Key offerings
o Exhibit 130: Biocon Ltd. – Segment focus
o 12.6 Dr Reddys Laboratories Ltd.
o Exhibit 131: Dr Reddys Laboratories Ltd. – Overview
o Exhibit 132: Dr Reddys Laboratories Ltd. – Business segments
o Exhibit 133: Dr Reddys Laboratories Ltd. – Key offerings
o Exhibit 134: Dr Reddys Laboratories Ltd. – Segment focus
o 12.7 F. Hoffmann La Roche Ltd.
o Exhibit 135: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 136: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 137: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 138: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 139: F. Hoffmann La Roche Ltd. – Segment focus
o 12.8 GlaxoSmithKline Plc
o Exhibit 140: GlaxoSmithKline Plc – Overview
o Exhibit 141: GlaxoSmithKline Plc – Business segments
o Exhibit 142: GlaxoSmithKline Plc – Key news
o Exhibit 143: GlaxoSmithKline Plc – Key offerings
o Exhibit 144: GlaxoSmithKline Plc – Segment focus
o 12.9 Glenmark Pharmaceuticals Ltd.
o Exhibit 145: Glenmark Pharmaceuticals Ltd. – Overview
o Exhibit 146: Glenmark Pharmaceuticals Ltd. – Product / Service
o Exhibit 147: Glenmark Pharmaceuticals Ltd. – Key offerings
o 12.10 Intas Pharmaceuticals Ltd.
o Exhibit 148: Intas Pharmaceuticals Ltd. – Overview
o Exhibit 149: Intas Pharmaceuticals Ltd. – Product / Service
o Exhibit 150: Intas Pharmaceuticals Ltd. – Key offerings
o 12.11 LEO Pharma AS
o Exhibit 151: LEO Pharma AS – Overview
o Exhibit 152: LEO Pharma AS – Business segments
o Exhibit 153: LEO Pharma AS – Key offerings
o Exhibit 154: LEO Pharma AS – Segment focus
o 12.12 Lupin Ltd.
o Exhibit 155: Lupin Ltd. – Overview
o Exhibit 156: Lupin Ltd. – Product / Service
o Exhibit 157: Lupin Ltd. – Key news
o Exhibit 158: Lupin Ltd. – Key offerings
o 12.13 Novartis AG
o Exhibit 159: Novartis AG – Overview
o Exhibit 160: Novartis AG – Business segments
o Exhibit 161: Novartis AG – Key offerings
o Exhibit 162: Novartis AG – Segment focus
o 12.14 Panacea Biotec Ltd.
o Exhibit 163: Panacea Biotec Ltd. – Overview
o Exhibit 164: Panacea Biotec Ltd. – Product / Service
o Exhibit 165: Panacea Biotec Ltd. – Key offerings
o 12.15 Pfizer Inc.
o Exhibit 166: Pfizer Inc. – Overview
o Exhibit 167: Pfizer Inc. – Product / Service
o Exhibit 168: Pfizer Inc. – Key news
o Exhibit 169: Pfizer Inc. – Key offerings
o 12.16 Sun Pharmaceutical Industries Ltd.
o Exhibit 170: Sun Pharmaceutical Industries Ltd. – Overview
o Exhibit 171: Sun Pharmaceutical Industries Ltd. – Product / Service
o Exhibit 172: Sun Pharmaceutical Industries Ltd. – Key offerings
o 12.17 Teva Pharmaceutical Industries Ltd.
o Exhibit 173: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 174: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 175: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 176: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 177: Teva Pharmaceutical Industries Ltd. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 178: Inclusions checklist
o Exhibit 179: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 180: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 181: Research methodology
o Exhibit 182: Validation techniques employed for market sizing
o Exhibit 183: Information sources
o 13.5 List of abbreviations
o Exhibit 184: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Drug Class
Exhibits6: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size – Data Table on global heart transplantation therapeutics market 2018 – 2022 ($ million)
Exhibits19: Historic Market Size – Drug Class Segment 2018 – 2022 ($ million)
Exhibits20: Historic Market Size – Distribution Channel Segment 2018 – 2022 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2018 – 2022 ($ million)
Exhibits22: Historic Market Size – Country Segment 2018 – 2022 ($ million)
Exhibits23: Five forces analysis – Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants – Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes – Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry – Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition – Five forces 2023 and 2028
Exhibits30: Chart on Drug Class – Market share 2023-2028 (%)
Exhibits31: Data Table on Drug Class – Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Drug Class
Exhibits33: Data Table on Comparison by Drug Class
Exhibits34: Chart on Immunosuppressants – Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Immunosuppressants – Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Immunosuppressants – Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Immunosuppressants – Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Anti-infectives – Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Anti-infectives – Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Anti-infectives – Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Anti-infectives – Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Analgesics – Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on Analgesics – Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on Analgesics – Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Analgesics – Year-over-year growth 2023-2028 (%)
Exhibits46: Chart on Others – Market size and forecast 2023-2028 ($ million)
Exhibits47: Data Table on Others – Market size and forecast 2023-2028 ($ million)
Exhibits48: Chart on Others – Year-over-year growth 2023-2028 (%)
Exhibits49: Data Table on Others – Year-over-year growth 2023-2028 (%)
Exhibits50: Market opportunity by Drug Class ($ million)
Exhibits51: Data Table on Market opportunity by Drug Class ($ million)
Exhibits52: Chart on Distribution Channel – Market share 2023-2028 (%)
Exhibits53: Data Table on Distribution Channel – Market share 2023-2028 (%)
Exhibits54: Chart on Comparison by Distribution Channel
Exhibits55: Data Table on Comparison by Distribution Channel
Exhibits56: Chart on Hospital pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits57: Data Table on Hospital pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits58: Chart on Hospital pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Hospital pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Retail pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits61: Data Table on Retail pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits62: Chart on Retail pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Retail pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits64: Chart on Online pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits65: Data Table on Online pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits66: Chart on Online pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits67: Data Table on Online pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits68: Market opportunity by Distribution Channel ($ million)
Exhibits69: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on North America – Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on North America – Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on North America – Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on North America – Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on Europe – Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Europe – Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on Asia – Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Asia – Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on US – Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on US – Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on US – Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on US – Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on Germany – Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Germany – Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on UK – Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on UK – Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on UK – Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on UK – Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on Japan – Market size and forecast 2023-2028 ($ million)
Exhibits104: Data Table on Japan – Market size and forecast 2023-2028 ($ million)
Exhibits105: Chart on Japan – Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on Japan – Year-over-year growth 2023-2028 (%)
Exhibits107: Chart on France – Market size and forecast 2023-2028 ($ million)
Exhibits108: Data Table on France – Market size and forecast 2023-2028 ($ million)
Exhibits109: Chart on France – Year-over-year growth 2023-2028 (%)
Exhibits110: Data Table on France – Year-over-year growth 2023-2028 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ million)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits113: Impact of drivers and challenges in 2023 and 2028
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: AbbVie Inc. – Overview
Exhibits120: AbbVie Inc. – Product / Service
Exhibits121: AbbVie Inc. – Key news
Exhibits122: AbbVie Inc. – Key offerings
Exhibits123: Astellas Pharma Inc. – Overview
Exhibits124: Astellas Pharma Inc. – Product / Service
Exhibits125: Astellas Pharma Inc. – Key news
Exhibits126: Astellas Pharma Inc. – Key offerings
Exhibits127: Biocon Ltd. – Overview
Exhibits128: Biocon Ltd. – Business segments
Exhibits129: Biocon Ltd. – Key offerings
Exhibits130: Biocon Ltd. – Segment focus
Exhibits131: Dr Reddys Laboratories Ltd. – Overview
Exhibits132: Dr Reddys Laboratories Ltd. – Business segments
Exhibits133: Dr Reddys Laboratories Ltd. – Key offerings
Exhibits134: Dr Reddys Laboratories Ltd. – Segment focus
Exhibits135: F. Hoffmann La Roche Ltd. – Overview
Exhibits136: F. Hoffmann La Roche Ltd. – Business segments
Exhibits137: F. Hoffmann La Roche Ltd. – Key news
Exhibits138: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits139: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits140: GlaxoSmithKline Plc – Overview
Exhibits141: GlaxoSmithKline Plc – Business segments
Exhibits142: GlaxoSmithKline Plc – Key news
Exhibits143: GlaxoSmithKline Plc – Key offerings
Exhibits144: GlaxoSmithKline Plc – Segment focus
Exhibits145: Glenmark Pharmaceuticals Ltd. – Overview
Exhibits146: Glenmark Pharmaceuticals Ltd. – Product / Service
Exhibits147: Glenmark Pharmaceuticals Ltd. – Key offerings
Exhibits148: Intas Pharmaceuticals Ltd. – Overview
Exhibits149: Intas Pharmaceuticals Ltd. – Product / Service
Exhibits150: Intas Pharmaceuticals Ltd. – Key offerings
Exhibits151: LEO Pharma AS – Overview
Exhibits152: LEO Pharma AS – Business segments
Exhibits153: LEO Pharma AS – Key offerings
Exhibits154: LEO Pharma AS – Segment focus
Exhibits155: Lupin Ltd. – Overview
Exhibits156: Lupin Ltd. – Product / Service
Exhibits157: Lupin Ltd. – Key news
Exhibits158: Lupin Ltd. – Key offerings
Exhibits159: Novartis AG – Overview
Exhibits160: Novartis AG – Business segments
Exhibits161: Novartis AG – Key offerings
Exhibits162: Novartis AG – Segment focus
Exhibits163: Panacea Biotec Ltd. – Overview
Exhibits164: Panacea Biotec Ltd. – Product / Service
Exhibits165: Panacea Biotec Ltd. – Key offerings
Exhibits166: Pfizer Inc. – Overview
Exhibits167: Pfizer Inc. – Product / Service
Exhibits168: Pfizer Inc. – Key news
Exhibits169: Pfizer Inc. – Key offerings
Exhibits170: Sun Pharmaceutical Industries Ltd. – Overview
Exhibits171: Sun Pharmaceutical Industries Ltd. – Product / Service
Exhibits172: Sun Pharmaceutical Industries Ltd. – Key offerings
Exhibits173: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits174: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits175: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits176: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits177: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits178: Inclusions checklist
Exhibits179: Exclusions checklist
Exhibits180: Currency conversion rates for US$
Exhibits181: Research methodology
Exhibits182: Validation techniques employed for market sizing
Exhibits183: Information sources
Exhibits184: List of abbreviations



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 心臓移植治療の世界市場2024~2028(Global Heart Transplantation Therapeutics Market 2024-2028)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆